Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Nektar Therapeutics (NASDAQ: NKTR) closed at $0.86 in the last session, down -1.10% from day before closing price of $0.87. In other words, the price has decreased by -$1.10 from its previous closing price. On the day, 1.41 million shares were traded. NKTR stock price reached its highest trading level at $0.87 during the session, while it also had its lowest trading level at $0.8232.
Ratios:
We take a closer look at NKTR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.26 and its Current Ratio is at 4.26. In the meantime, Its Debt-to-Equity ratio is 3.20 whereas as Long-Term Debt/Eq ratio is at 2.87.
On January 08, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $4.
On December 10, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $6.50.H.C. Wainwright initiated its Buy rating on December 10, 2024, with a $6.50 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 19 ’25 when Zalevsky Jonathan sold 10,300 shares for $1.01 per share. The transaction valued at 10,403 led to the insider holds 316,604 shares of the business.
Wilson Mark Andrew sold 11,040 shares of NKTR for $11,150 on Feb 19 ’25. The Chief Legal Officer now owns 324,292 shares after completing the transaction at $1.01 per share. On Feb 19 ’25, another insider, ROBIN HOWARD W, who serves as the President & CEO of the company, sold 23,774 shares for $1.01 each. As a result, the insider received 24,012 and left with 1,086,901 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NKTR now has a Market Capitalization of 160738016 and an Enterprise Value of 99851672. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.63 while its Price-to-Book (P/B) ratio in mrq is 2.64. Its current Enterprise Value per Revenue stands at 1.014 whereas that against EBITDA is -0.795.
Stock Price History:
The Beta on a monthly basis for NKTR is 0.58, which has changed by -0.033707857 over the last 52 weeks, in comparison to a change of 0.086116076 over the same period for the S&P500. Over the past 52 weeks, NKTR has reached a high of $1.93, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 0.05%, while the 200-Day Moving Average is calculated to be -23.59%.
Shares Statistics:
According to the various share statistics, NKTR traded on average about 2.00M shares per day over the past 3-months and 1437170 shares per day over the past 10 days. A total of 185.78M shares are outstanding, with a floating share count of 179.37M. Insiders hold about 3.62% of the company’s shares, while institutions hold 70.10% stake in the company. Shares short for NKTR as of 1740700800 were 6624341 with a Short Ratio of 3.31, compared to 1738281600 on 5757355. Therefore, it implies a Short% of Shares Outstanding of 6624341 and a Short% of Float of 4.5900002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
